CI

At a glance

ClinicalIndex Comparison Record
Phase 2Completed· 32 enrolled
Drug / intervention
90 grams of Crystalline Lactulose +2 moredrug
Likely dose
90 grams of Crystalline Lactulose 15 mgfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02123017
NCT02123017Phase 2Completed

An Observer-blinded, Dose-finding Study to Investigate the Safety, Efficacy, and Patient Preference of Lactulose for Oral Solution With Bisacodyl for Cleansing of the Colon as a Preparation for Colonoscopy in Adults

Cumberland Pharmaceuticals·interventional·Posted Apr 25, 2014·Updated Feb 24, 2016

In Brief

A Phase 2 clinical trial evaluating 90 grams of Crystalline Lactulose, 135 grams of Crystalline Lactulose, and 1 other intervention for Colonoscopy Preparation. Completed, enrolled 32 participants across 1 site.

Detailed Summary

The purpose of the study is to evaluate the efficacy and safety of bisacodyl combined with escalating doses of lactulose to be used as a preparation for colonoscopy.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesUnited States
Collaborators--

Timeline

Phase 2CompletedFinished
2014201520162017201820192020202120222023202420252026
First PostedApr 25, 2014
Enrollment StartApr 1, 2014
Primary CompletionAug 1, 2014
TodayJul 2, 2026
Enrollment to primary: 4 monthsPosted 12.2 years ago

Interventions

90 grams of Crystalline Lactulosedrug

15 mg of bisacodyl, plus 30 grams crystalline lactulose x 3 doses

135 grams of Crystalline Lactulosedrug

15 mg of bisacodyl, plus 45 grams crystalline lactulose x 3 doses

180 grams of Crystalline Lactulosedrug

15 mg of bisacodyl, plus 60 grams crystalline lactulose x 3 doses